Merck KGaA Acquires Bioscience Company in India
Merck KGaA announced the acquisition of Bangalore Genei (India) Private Ltd. (BGIP) by its wholly owned subsidiary in India, Merck Specialities Private Ltd., from the Sanmar Group.
BGIP is located in Bangalore and specializes in the development, production, marketing and sales of products for proteomic and genomic research. With more than 100 employees, the company generated total revenues of INR 202m (€ 3.0 million) in fiscal year 2008/09.
Christina Shasserre, Global Head of Merck's bioscience business, commented: "BGIP’s leadership in the Indian academic market, a segment with high growth potential, will ideally complement our existing customer base. BGIP’s product portfolio comprises a wide range of bioscience products, which are tailored to the needs of the domestic market in India."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.